Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Google Scholar citation report
Indexed In
- Index Copernicus
- Google Scholar
- CiteFactor
- Publons
- Pubmed
- science Gate
- scispace
- world cat
Useful Links
Related Subjects
Share This Page
Atherosclerosis and changed iron metabolism in chronic kidney disease
29th International Conference on Public Mental Health and Neuroscience
Victor Manolov
Medical University Sofia, Bulgaria
ScientificTracks Abstracts: Int J Emerg Ment Health
Abstract
Chronic kidney disease (CKD) involves high number of population worldwide, which on its way increases brain-vascular diseases risk. Among the main reasons for increased brain disorders evidence in patients with CKD is iron homeostasis disregulation. Impairment of brain cognitive function is an early sign of atherosclerosis development. 65 patients with chronic kidney disease (stages II to V, incl on dialysis) were included; age 48.8 ± 6.9. Their results were compared to sex and age matched healthy control and with CKD patients with no atherosclerotic changes. Routine blood analyses as CBC, serum iron, ferritin, hsCRP and specific hepcidin were measured in the included groups. IMT, MMSE, CERAD tests were used for atherosclerotic changes evaluation. We found increased serum hepcidin levels in CKD patients with IMT, MMSE, CERAD changes (201.8 ± 14.7 μg/L) compared to healthy controls (20.7 ± 1.9 μg/L) and CKD with no atherosclerotic changes group (174.4 ± 11.8 μg/L); P<0.005. A positive correlation was found in CKD patients with brain disorders between IMT and serum hepcidin levels (r=0.838, P<0.01). Serum hepcidin correlates positively to atherosclerotic evidence changes in patients with impaired kidney function (r=0.810, P<0.01). Brain-vascular disease risk factors are connected to chronic kidney function impairment. Disregulation of iron homeostasis is one of the main risk atherogenesis factors. Early hepcidin quantification might predict cognitive disturbances as atherosclerosis symptoms in chronic kidney disease patients, which might be very important for better clinical diagnosis and practice. Acknowledgements: This project is sponsored by MU-Sofia, as part of Grant Д-235/2017.Biography
Victor Manolov has completed his PhD at Medical University in Sofia, Bulgaria. He is working as Assist. Prof. at Department of Clinical laboratory and clinical immunology at the same University. His interests are in neurology, pediatrics, gynecology, endocrinology and clinical laboratory. He has published more than 20 papers in reputed journals.
E-mail: victhedoc4@abv.bg
